Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

HGF combined with ADA is highly accurate for diagnosing tuberculous pleural effusion, especially in younger females.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Tofacitinib effectively treats Alopecia Areata.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib is effective and safe for treating alopecia areata.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

About 20-25% of people recovering from coronavirus experience hair loss, causing discomfort and anxiety.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Tofacitinib helped regrow hair in most patients with severe hair loss.